Kaliumchloride Natriumchloride B. Braun

Potassium chloride and sodium chloride, the active ingredients in Kaliumchloride Natriumchloride B. Braun, are electrolyte solutions presented as an injection solution for intravenous use. They replace potassium and sodium ions to correct electrolyte imbalances such as hypokalemia and hyponatremia in hospitalized patients.

GNH USA supplies Kaliumchloride Natriumchloride B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumchloride Natriumchloride B. Braun is an injectable electrolyte solution used to correct disturbances in body fluid electrolytes. - Hypokalemia: restores low potassium levels to normal range. - Hyponatremia: provides sodium to correct low serum sodium. - General electrolyte replacement: supports overall electrolyte balance during surgery, trauma, or intensive care.

Adverse reactions may occur with intravenous electrolyte administration.

Common Side Effects: - Pain or irritation at the injection site. - Mild nausea or vomiting. - Transient headache. - Slight increase in serum chloride. - Temporary rise in blood pressure. - Mild hyperglycemia.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Hypernatremia causing neurological symptoms. - Anaphylactic reaction or severe hypersensitivity. - Phlebitis or thrombophlebitis at the infusion site. - Acute kidney injury due to electrolyte overload. - Metabolic acidosis in susceptible patients.

When using Kaliumchloride Natriumchloride B. Braun, clinicians should consider patient-specific factors and monitor laboratory values. - Renal function: assess creatinine clearance before and during therapy. - Cardiac status: monitor ECG for arrhythmias, especially in patients with cardiac disease. - Fluid balance: avoid overload in patients with heart failure or edema. - Concomitant electrolytes: adjust doses if other potassium or sodium sources are administered. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Electrolyte solutions can interact with other medications affecting ion balance.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may potentiate hyperkalemia. - Potassium-sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia. - Sodium bicarbonate: can cause rapid shifts in serum sodium.

Moderate Interactions (Monitor Closely): - Digoxin: altered potassium levels affect drug toxicity. - Beta‑blockers: may mask hypoglycemia symptoms when combined with electrolyte shifts. - Insulin therapy: rapid potassium shifts can affect glucose control.